Your browser doesn't support javascript.
loading
Reduced cyclooxygenase 2 levels after hypoxia exposure result in the loss of immunoprivilege of allogeneic mesenchymal stem cells.
Sareen, Niketa; Yan, Weiang; Verma, Elika; Lionetti, Vincenzo; Dhingra, Sanjiv.
Afiliación
  • Sareen N; Cardiac Regeneration and Tissue Engineering Laboratory, Department of Physiology & Pathophysiology, Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Center, University of Manitoba, R2H 2A6 Winnipeg, Canada.
  • Yan W; Cardiac Regeneration and Tissue Engineering Laboratory, Department of Physiology & Pathophysiology, Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Center, University of Manitoba, R2H 2A6 Winnipeg, Canada.
  • Verma E; Cardiac Regeneration and Tissue Engineering Laboratory, Department of Physiology & Pathophysiology, Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Center, University of Manitoba, R2H 2A6 Winnipeg, Canada.
  • Lionetti V; Unit of Translational Critical Care Medicine, Institute of Life Sciences, Scuola Superiore Sant'Anna, 56124 Pisa, Italy.
  • Dhingra S; Cardiac Regeneration and Tissue Engineering Laboratory, Department of Physiology & Pathophysiology, Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Center, University of Manitoba, R2H 2A6 Winnipeg, Canada.
Vascul Pharmacol ; 155: 107351, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38985629

Texto completo: 1 Colección: 01-internacional Asunto principal: Hipoxia de la Célula / Ciclooxigenasa 2 / Células Madre Mesenquimatosas Límite: Animals / Humans Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Asunto principal: Hipoxia de la Célula / Ciclooxigenasa 2 / Células Madre Mesenquimatosas Límite: Animals / Humans Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Canadá